532 related articles for article (PubMed ID: 18930904)
21. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
Zhang X; Leung YK; Ho SM
Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739
[TBL] [Abstract][Full Text] [Related]
22. Cell-type-specific transcription factor interactions with cis-elements present in the mouse LDH/C proximal promoter region.
Yang J; Riley M; Thomas K
J Exp Zool; 1998 Sep-Oct 1; 282(1-2):179-87. PubMed ID: 9723175
[TBL] [Abstract][Full Text] [Related]
23. The role of CpG methylation in cell type-specific expression of the aquaporin-5 gene.
Nomura J; Hisatsune A; Miyata T; Isohama Y
Biochem Biophys Res Commun; 2007 Feb; 353(4):1017-22. PubMed ID: 17198683
[TBL] [Abstract][Full Text] [Related]
24. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
25. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
26. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C
Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
[TBL] [Abstract][Full Text] [Related]
27. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
[TBL] [Abstract][Full Text] [Related]
28. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
[TBL] [Abstract][Full Text] [Related]
29. CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site.
Mancini DN; Rodenhiser DI; Ainsworth PJ; O'Malley FP; Singh SM; Xing W; Archer TK
Oncogene; 1998 Mar; 16(9):1161-9. PubMed ID: 9528858
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
[TBL] [Abstract][Full Text] [Related]
31. Expression of the human Sd(a) beta-1,4-N-acetylgalactosaminyltransferase II gene is dependent on the promoter methylation status.
Wang HR; Hsieh CY; Twu YC; Yu LC
Glycobiology; 2008 Jan; 18(1):104-13. PubMed ID: 17965433
[TBL] [Abstract][Full Text] [Related]
32. Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression.
Roger T; Ding X; Chanson AL; Renner P; Calandra T
Eur J Immunol; 2007 Dec; 37(12):3509-21. PubMed ID: 18034423
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter.
Kuzmin I; Geil L; Gibson L; Cavinato T; Loukinov D; Lobanenkov V; Lerman MI
J Mol Biol; 2005 Feb; 346(2):411-22. PubMed ID: 15670593
[TBL] [Abstract][Full Text] [Related]
34. Methylation of CpG dinucleotides alters binding and silences testis-specific transcription directed by the mouse lactate dehydrogenase C promoter.
Kroft TL; Jethanandani P; McLean DJ; Goldberg E
Biol Reprod; 2001 Nov; 65(5):1522-7. PubMed ID: 11673270
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of CpG methylation in the BRCA1 promoter region.
DiNardo DN; Butcher DT; Robinson DP; Archer TK; Rodenhiser DI
Oncogene; 2001 Aug; 20(38):5331-40. PubMed ID: 11536045
[TBL] [Abstract][Full Text] [Related]
36. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors.
Stirzaker C; Millar DS; Paul CL; Warnecke PM; Harrison J; Vincent PC; Frommer M; Clark SJ
Cancer Res; 1997 Jun; 57(11):2229-37. PubMed ID: 9187126
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
[TBL] [Abstract][Full Text] [Related]
38. Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-beta3.
Archey WB; Sweet MP; Alig GC; Arrick BA
Cancer Res; 1999 May; 59(10):2292-6. PubMed ID: 10344731
[TBL] [Abstract][Full Text] [Related]
39. The CpG-rich promoter of human LDH-C is differentially methylated in expressing and nonexpressing tissues.
Bonny C; Goldberg E
Dev Genet; 1995; 16(2):210-7. PubMed ID: 7736669
[TBL] [Abstract][Full Text] [Related]
40. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
